An open-label clinical trial of the combination treatment of tacrolimus and corticosteroid in polymyositis/dermatomyositis patients with interstitial pneumonitis, with comparison against corticosteroid-treated historical controls

Trial Profile

An open-label clinical trial of the combination treatment of tacrolimus and corticosteroid in polymyositis/dermatomyositis patients with interstitial pneumonitis, with comparison against corticosteroid-treated historical controls

Completed
Phase of Trial: Phase II/III

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Dermatomyositis; Pneumonitis; Polymyositis
  • Focus Therapeutic Use
  • Acronyms IMPPACT
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 06 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top